More on the 2018 update of “Clinical classification of rare cardiovascular diseases and disorders”
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2019, Vol 3, Issue 8
Abstract
n/a
Authors and Affiliations
Piotr Podolec
Keywords
Related Articles
- EP ID EP491782
- DOI 10.2041/jrcd.vol3no8.367
- Views 92
- Downloads 0
Doxorubicin cardiomyopathy – case report and review of histopathologic findings (RCD code: III‐1B.5a)
The anthracycline anticancer drug Doxorubicin (Adriamycin) is an effective and frequently used chemotherapeutic agent for various malignancies. The use of doxorubicin is limited by its major adverse effect, cardiotoxicit...
Brugada syndrome: current diagnostics, epidemiology, genetic data and novel mechanisms (RCD code: V‑1A.1)
Brugada syndrome (BrS) is a cardiac channelopathy associated with ventricular arrhythmias and sudden cardiac death. Diagnosis of BrS is based on type 1 BrS electrocardiogram (ECG) pattern (coved pattern) presence, observ...
Report from the 66th American College of Cardiology Congress 2016 in Washington, DC, USA
N/A
An uncommon cause of right heart failure: primary cardiac pre-B cell acute lymphoblastic leukemia (RCD code: VI-2C.1).
Hematological malignancies are protean in their presentations. Primary cardiac tumors are exceedingly rare, and primary cardiac leukemia presenting as an isolated mass is even rare. Here, we present a case of a young man...
Arrhythmias in pregnancy (RCD code: VII‑V)
Cardiovascular diseases in pregnancy are the most common causes of maternal mortality in developed world and an important cause of heart failure, stroke, and arrhythmia. Cardiac disease complicates 0.4–4% of all pregnanc...